HCL forays in technology support for pharma sector with tie up with Eli Lilly

Posted By:

HCL ties up with Eli Lilly
HCL Technologies: Quotes, News
BSE 804.15BSE Quote6.55 (0.81%)
NSE 804.55NSE Quote6.1 (0.76%)
Eli Lilly, a global pharmaceutical corporation and HCL Technologies (HCL), a leading global IT services provider announced the opening of a Co-Innovation Lab in Singapore for developing technologies and improve operational efficiencies to enhance Eli Lilly"s global competitiveness.

This unique collaboration aims at accelerating the process of implementing the ideas through the Co-Innovation lab. To achieve business results learning from multiple industries such as banking, government, insurance, manufacturing, telecom as well as pharmaceuticals will be put to use for optimum results.

HCL will utilize its services such as cloud computing, automation, business analytics, enterprise mobility etc. plus the domain expertise in numerous areas to create innovative applications and solutions. These applications and solutions will be used to support Eli Lilly"s global operations.

Co-Innovation Lab will help the two companies to extend the scale and scope of external partnerships and alliances.

The laboratory, which will act as a key component of Eli Lilly"s IT Innovation strategy, was inaugurated by Michael C. Heim, Senior Vice President and Chief Information Officer, Eli Lilly and Company.

Michael C. Heim Senior Vice President and Chief Information Officer, Eli Lilly said on the occasion of inaugration said, “We are delighted to launch this Co-Innovation Lab with HCL which will serve as a center for our company"s efforts to leverage IT to create competitive differentiators for our business.

The HCL-Eli Lilly Co-Innovation Lab will be housed in a 35000 sq ft dedicated space in HCL"s Jurong Development Center in Singapore and bring together a diverse set of partners and local/global talent to ensure a swift pursuit of business-aligned IT solutions.

HCL, which already has over 1,000 engineers based out of the facility, will work closely with the government of Singapore to ensure the lab becomes a global hub of IT innovation in the pharmaceutical industry. The Lab will also be front-ending a close collaboration with educational and academic research centers across the globe to meet these objectives.

Speaking on the occasion of the formal opening of the facility, Mr. Virender Aggarwal, President and Head of APAC- MEA region for HCL said, “We want to thank Eli Lilly for the trust reposed in us. We have partnered very closely with Eli Lilly over the last several years, beginning with highly successful collaborations in the Emerging Markets and Japan, which have been leveraged as centres of technology innovation by Piers Shore, Vice President, Information Technology, Eli Lilly and Company.

HCL has also opened a Global Enterprise Mobility Lab recently in Singapore and continues to invest in the country in light of its excellent infrastructure, supportive government policies, availability of highly skilled talent pool and high concentration of global MNCs and premier educational institutions.

OneIndia Money

Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

Thousands of Goodreturn readers receive our evening newsletter.
Have you subscribed?